News
European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.
Results from the Phase III PREVAIL trial (NCT05556096) of gefurulimab demonstrated a statistically significant and clinically ...
In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.
MRK is gearing up to report Q2 earnings. While Keytruda drives growth, there are concerns over Gardasil's China sales, generics and pipeline depth.
10h
MedPage Today on MSN'Early COPD' Linked to Poor Outcomes for Younger Adults
Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...
President Trump is settling on a new baseline tariff rate as the US clinched a trade deal with Japan and made progress toward ...
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
Colorcon, Inc. (Harleysville, Pa.), a manufacturer of of film coating systems, specialty excipients, controlled release ...
Another FTSE 100-listed (^FTSE) giant reporting in the week ahead is pharmaceuticals company AstraZeneca (AZN.L), which has ...
With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...
With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...
A Venezuelan baseball team was denied visas into the United States and will miss this year's Senior Baseball World Series, Little League International confirmed Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results